Complicated Intra-Abdominal Infections (cIAIs) Completed Phase 2 Trials for Metronidazole (DB00916)

Also known as: Complicated Intra-abdominal Infection (cIAI) / Complicated Intra-Abdominal Infections, cIAIs / Complicated Intraabdominal Infections / Intra Abdominal Infections Complicated / Complicated Intra Abdominal Infections / Complicated Intra-Abdominal Infection / Complicated Intra-Abdominal Infections / Abdominal infection / Infectious disease of abdomen (disorder) / Intra-abdominal infection / Intraabdominal Infections

IndicationStatusPhase
DBCOND0079243 (Complicated Intra-Abdominal Infections (cIAIs))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02655419Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)Treatment
NCT03217136MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)Treatment
NCT01147640Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal InfectionsTreatment
NCT00752219Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal InfectionsTreatment
NCT02475733Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).Treatment